Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15
August 6, 2015 6:46 AM EDT
JPMorgan upgraded Endologix (NASDAQ: ELGX) from Neutral to Overweight with a price target of $17.00.
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $12.05 yesterday.
...
More
August 4, 2015 7:03 AM EDT
Canaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.06 yesterday.
...
More
August 3, 2015 4:08 PM EDT
Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
...
More
July 31, 2015 3:34 PM EDT
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Personal Income - Street sees 0.3%Personal Spending - Street sees 0.2%PCE Prices: Core - Street sees 0.2%
Earnings:
ArcBest (Nasdaq: ARCB) - consensus EPS $0.76
Array Biopharma (Nasdaq: ARRY) - consensus loss $0.16
Boardwalk Pipeline Partners (NYSE: BWP) - no Street consensus
Broadsoft (Nasdaq:... More
